Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study

Journal of Alzheimer's Disease

Volumn 46, Issue 4, 2015, Pages 1079-1089

  Burnham, Samantha C ^a   Raghavan, Nandini ^b   Wilson, William ^a   Baker, David ^b   Ropacki, Michael T ^c   Novak, Gerald ^b   Ames, David ^d,e   Ellis, Kathryn ^d   Martins, Ralph N ^f,g   Maruff, Paul ^h   Masters, Colin L ^d   Romano, Gary ^b   Rowe, Christopher C ^d,i   Savage, Greg ^j   Macaulay, S Lance ^a   Narayan, Vaibhav A ^b  

^a CSIRO   (Australia)

^b JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^c JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e NATIONAL AGEING RESEARCH INSTITUTE   (Australia)

^f EDITH COWAN UNIVERSITY   (Australia)

^g HOLLYWOOD PRIVATE HOSPITAL   (Australia)

^h Scientific Division   (Australia)

ⁱ AUSTIN HEALTH   (Australia)

^j MACQUARIE UNIVERSITY   (Australia)

more..

Author keywords

Alzheimer's disease; clinical marker; clinical trial; mild cognitive impairment; prodromal stage

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; BIOLOGICAL MARKER; 2-(4'-(METHYLAMINO)PHENYL)-6-HYDROXYBENZOTHIAZOLE; ANILINE DERIVATIVE; APOLIPOPROTEIN E; THIAZOLE DERIVATIVE;

AGED; ALZHEIMER DISEASE; ARTICLE; AUSTRALIA; CLINICAL ARTICLE; CLINICAL DEMENTIA RATING; COGNITION; DISEASE COURSE; EPISODIC MEMORY; EXECUTIVE FUNCTION; FEMALE; FOLLOW UP; GERIATRIC DEPRESSION SCALE; HUMAN; INTELLIGENCE QUOTIENT; LIFESTYLE; LONGITUDINAL STUDY; MALE; MENTAL DETERIORATION; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECALL; RECOGNITION; STROOP TEST; WECHSLER INTELLIGENCE SCALE; GENETICS; MENTAL HEALTH; METABOLISM; PROCEDURES; PRODROMAL SYMPTOM; PSYCHOLOGY; REPRODUCIBILITY;

AGED; ALZHEIMER DISEASE; ANILINE COMPOUNDS; APOLIPOPROTEINS E; AUSTRALIA; BIOMARKERS; DISEASE PROGRESSION; FEMALE; HUMANS; LIFE STYLE; LONGITUDINAL STUDIES; MALE; MENTAL STATUS SCHEDULE; NEUROIMAGING; NEUROPSYCHOLOGICAL TESTS; PRODROMAL SYMPTOMS; REPRODUCIBILITY OF RESULTS; THIAZOLES;

EID: 84937036549     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-143015     Document Type: Article

References (33)

1. Rosen WG, Mohs RC, Davis KL (1984) A new rating scale for Alzheimer's disease. Am J Psychiatry 141(11), 1356-1364.
2. Cano SJ, Posner HB, Moline ML, Hurt SW, Swartz J, Hsu T, Hobart JC (2010) The ADAS-cog in Alzheimer's disease clinical trials: Psychometric evaluation of the sum and its parts. J Neurol Neurosurg Psychiatry 81, 1363-1368.
3. Hobart J, Cano S, Posner H, Selnes O, Stern Y, Thomas R, Zajicek J (2013) Putting the Alzheimer's cognitive test to the test I: Traditional psychometric methods. Alzheimers Dement 9, S4-S9.
4. Hobart J, Cano S, Posner H, Selnes O, Stern Y, Thomas R, Zajicek J (2013) Putting the Alzheimer's cognitive test to the test II: Rasch Measurement Theory. Alzheimers Dement 9, S10-S20.
5. Raghavan N, Samtani MN, Farnum M, Yang E, Novak G, Grundman M, Narayan V, DiBernardo A (2013) The ADAS-Cog revisited: Novel composite scales based on ADAS-Cog to improve efficiency in MCI and early AD trials. Alzheimers Dement 9, S21-S31.
6. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH (2011) The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 270-279.
7. Wessels AM, Raghavan N, Yu P (2014) Retrofitting existing tools across the Alzheimer's disease spectrum. Alzheimers Dement 10, 244-245.
8. Donohue M, Sperling R, Salmon D, Rentz D, Raman R, Thomas R, Weiner M, Aisen P (2014) The preclinical Alzheimer cognitive composite: Measuring amyloid-related decline. JAMA Neurol 71, 961-970.
9. Ellis KA, Bush AI, Darby D, De Fazio D, Foster J, Hudson P, Lautenschlager NI, Lenzo N, Martins RN, Maruff P, Masters C, Milner A, Pike K, Rowe C, Savage G, Szoeke C, Taddei K, Villemagne V, Woodward M, Ames D, Grp AR (2009) The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: Methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease. Int Psychogeriatr 21, 672-687.
10. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical-Diagnosis of Alzheimers-Disease - Report of the NINCDS-ADRDA Work Group under the Auspices of Department-of-Health-and-Human-Services Task-Force on Alzheimers-Disease. Neurology 34, 939-944.
11. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Backman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC (2004) Mild cognitive impairment - beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment. J Intern Med 256, 240-246.
12. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment - Clinical characterization and outcome. Arch Neurol 56, 303-308.
13. Petersen RC, Aisen PS, Beckett LA, Donohue MC, Gamst AC, Harvey DJ, Jack CR Jr, Jagust WJ, Shaw LM, Toga AW, Trojanowski JQ, Weiner MW (2010) Alzheimer's Disease Neuroimaging Initiative (ADNI) clinical characterization. Neurology 74, 201-209.
14. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state": A practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res 12, 189-198.
15. Delis D, Kramer J, Kaplan E, Ober B (2000) California Verbal Learning Test-Second Edition. The Psychological Corporation, San Antonio, TX.
16. Wechsler D (1945) A standardized memory scale for clinical use. J Psychol 19, 87-95.
17. Strauss E, Sherman EMS, Spreen O (2006) A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary, 3rd ed, Oxford University Press, New York.
18. Wechsler D (1997) Wechsler Memory Scale - Third Edition, The Psychological Corporation, San Antonio.
19. Delis D, Kaplan E, Kramer J. (2001) Delis-Kaplan Executive Function System (D-KEFS). The Psychological Corporation, San Antonio, TX.
20. Saxton J, Ratcliff G, Munro CA, Coffey EC, Becker JT, Fried L, Kuller L (2000) Normative data on the Boston Naming Test and two equivalent 30-item short forms. Clin Neuropsychologist 14, 526-534.
21. Meyers J, Meyers K (1995) Rey Complex Figure Test and Recognition Trial. Professional Manual, Psychological Assessment Resource, Inc.
22. Wechsler D (1997) Wechsler Adult Intelligence Scale, 3rd Edition (WAIS III). The Psychological Corporation, San Antonio, TX.
23. Wechsler D (2001) Wechsler Test of Adult Reading: Examiner's Manual. The Psychological Corporation, San Antonio, TX.
24. Burnham S, Raghavan N, Wilson W, Baker D, Ropacki M, Novak G, Ames D, Ellis K, Martins R, Maruff P, Masters C, Romano G, Rowe C, Savage G, Twyman R, Macaulay L, Narayan V (2014) Comparison of Three Normative Data Correction Approaches: A Cross Sectional Evaluation in the AIBL Study. Elsevier, Alzheimer's Association International Conference.
25. Holtzer R, Goldin Y, Zimmerman M, Katz M, Buschke H, Lipton RB (2008) Robust norms for selected neuropsychological tests in older adults. Arch Clin Neuropsychol 23, 531-541.
26. Rowe CC, Ellis KA, Rimajova M, Bourgeat P, Pike KE, Jones G, Fripp J, Tochon-Danguy H, Morandeau L, O'Keefe G, Price R, Raniga P, Robins P, Acosta O, Lenzo N, Szoeke C, Salvado O, Head R, Martins R, Masters CL, Ames D, Villemagne VL (2010) Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiol Aging 31, 1275-1283.
27. Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R (2014) Advancing research diagnostic criteria for Alzheimer's disease: The IWG-2 criteria. Lancet Neurol 13, 614-629.
28. Liu G, Liang K-Y (1997) Sample size calculations for studies with correlated observations. Biometrics 53, 937-947.
29. Rey A (1958) L'examen clinique en psychologie.
30. Wechsler D (1987) Wechsler Memory Scale - Revised, The Psychological Corporation, San Antonio.
31. Huang Y, Ito K, Billing CB Jr, Anziano RJ (2015) Development of a straightforward and sensitive scale for MCI and early AD clinical trials. Alzheimers Dement 11, 404-414.
32. Hendrix SB (2012) Measuring clinical progression in MCI and pre-MCI populations: Enrichment and optimizing clinical outcomes over time. Alzheimers Res Ther 4, 24.
33. Harrington KD, Lim YY, Ellis KA, Copolov C, Darby D, Weinborn M, Ames D, Martins RN, Savage G, Szoeke C, Rowe C, Villemagne VL, Masters CL, Maruff P (2013) The association of A beta amyloid and composite cognitive measures in healthy older adults and MCI. Int Psychogeriatrics 25, 1667-1677.